64
Participants
Start Date
July 31, 2012
Primary Completion Date
May 17, 2017
Study Completion Date
May 17, 2017
WT2725
WT2725 injection Study drug will be administered every 1-4 weeks
Penn State Milton S. Hershey Medical Center, Hershey
The University of Chicago Medical Center, Chicago
The University of Texas MD Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center, Houston
The University of Arizona Cancer Center - North Campus, Tucson
UC San Diego Moores Cancer Center, La Jolla
Sumitomo Pharma Co., Ltd.
INDUSTRY
Sumitomo Pharma America, Inc.
INDUSTRY